AXIM BIOTECHNOLOGIES, INC. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Axim Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$569K, a 18.4% increase year-over-year.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$2.31M, a 40.2% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$2.75M, a 40.9% increase from 2022.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$4.65M, a 66.7% increase from 2021.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2021 was -$14M, a 182% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.75M +$1.9M +40.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$4.65M +$9.32M +66.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$14M -$9.03M -182% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$4.95M -$1.84M -59.2% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-04-19
2019 -$3.11M +$1.93M +38.3% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
2018 -$5.04M -$1.89M -59.9% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-05-20
2017 -$3.15M +$610K +16.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-08
2016 -$3.76M +$6.29M +62.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 -$10M -$9.54M -1887% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-09-14
2014 -$506K Jan 1, 2014 Dec 31, 2014 10-K/A 2016-04-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.